ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 123 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $196,000 | +14.0% | 12,374 | -8.5% | 0.00% | 0.0% |
| Q1 2018 | $172,000 | -25.5% | 13,517 | -32.9% | 0.00% | -50.0% |
| Q4 2017 | $231,000 | +71.1% | 20,132 | +273.3% | 0.00% | +100.0% |
| Q2 2016 | $135,000 | +90.1% | 5,393 | +85.5% | 0.00% | – |
| Q1 2016 | $71,000 | -4.1% | 2,908 | +29.6% | 0.00% | -100.0% |
| Q4 2015 | $74,000 | -21.3% | 2,243 | -21.8% | 0.00% | 0.0% |
| Q3 2015 | $94,000 | +141.0% | 2,870 | +289.9% | 0.00% | – |
| Q2 2015 | $39,000 | – | 736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |